Quintiles Transnational Holdings Inc (Q) : Incline Global Management scooped up 199 additional shares in Quintiles Transnational Holdings Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Aug 15, 2016. The investment management firm now holds a total of 407,262 shares of Quintiles Transnational Holdings Inc which is valued at $31,114,817.Quintiles Transnational Holdings Inc makes up approximately 7.20% of Incline Global Management’s portfolio.
Other Hedge Funds, Including , Amp Capital Investors Ltd reduced its stake in Q by selling 44,113 shares or 27.54% in the most recent quarter. The Hedge Fund company now holds 116,075 shares of Q which is valued at $8,868,130. Quintiles Transnational Holdings Inc makes up approx 0.06% of Amp Capital Investors Ltd’s portfolio.Meiji Yasuda Life Insurance Co boosted its stake in Q in the latest quarter, The investment management firm added 200 additional shares and now holds a total of 3,990 shares of Quintiles Transnational Holdings Inc which is valued at $304,836. Quintiles Transnational Holdings Inc makes up approx 0.05% of Meiji Yasuda Life Insurance Co’s portfolio.Mizuho Asset Managementltd. boosted its stake in Q in the latest quarter, The investment management firm added 463 additional shares and now holds a total of 1,092 shares of Quintiles Transnational Holdings Inc which is valued at $83,429. Quintiles Transnational Holdings Inc makes up approx 0.01% of Mizuho Asset Managementltd.’s portfolio.Bnp Paribas Investment Partners S.a. reduced its stake in Q by selling 4,951 shares or 10.15% in the most recent quarter. The Hedge Fund company now holds 43,810 shares of Q which is valued at $3,362,418. Quintiles Transnational Holdings Inc makes up approx 0.03% of Bnp Paribas Investment Partners S.a.’s portfolio.
Quintiles Transnational Holdings Inc opened for trading at $77.46 and hit $77.54 on the upside on Thursday, eventually ending the session at $77.42, with a gain of 0.16% or 0.12 points. The heightened volatility saw the trading volume jump to 7,20,025 shares. Company has a market cap of $9,173 M.
On the company’s financial health, Quintiles Transnational Holdings Inc reported $0.93 EPS for the quarter, beating the analyst consensus estimate by $ 0.03 according to the earnings call on Jul 27, 2016. Analyst had a consensus of $0.90. The company had revenue of $1167.10 million for the quarter, compared to analysts expectations of $1150.61 million. The company’s revenue was up 8.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.78 EPS.
Many Wall Street Analysts have commented on Quintiles Transnational Holdings Inc. Quintiles Transnational Holdings Inc was Upgraded by Avondale to ” Mkt Outperform” on Jul 12, 2016.
Quintiles Transnational Holdings Inc. is a biopharmaceutical services company. The Company is a provider of biopharmaceutical development services and commercial outsourcing services. The Company is engaged in the development and commercialization of pharmaceutical therapies. It also offers therapeutic scientific and analytical services to its biopharmaceutical and other healthcare customers. The Company offers its services through two segments: Product Development and Integrated Healthcare Services. Its product development segment is a contract research organization (CRO) and is focused on Phase II-IV clinical trials and associated laboratory and analytical activities. Its Integrated Healthcare Services segment provides services including commercial services such as contract pharmaceutical sales forces and healthcare business services such as phase research market access and consulting and health information analytics and technology consulting.